Streptomycin Manufacturing Plant Project Report 2026: Cost Analysis, ROI, and Feasibility Insights

The benchmark plant capacity is 50-200 MT/year of streptomycin sulfate.

The global streptomycin market size is estimated to be around USD 350 million to USD 550 million, with a projected compound annual growth rate (CAGR) of 4.0% to 5.0%.

The main end-use segments include tuberculosis treatment (40-50%), veterinary medicine (20-25%), agricultural crop protection (15-20%), and cell culture and research (10-15%).

Streptomycin is produced through submerged aerobic fermentation using Streptomyces griseus. The process includes inoculum preparation, fermentation, filtration of the harvested broth, ion-exchange adsorption, concentration, purification, and drying or crystallization to obtain streptomycin sulfate.

The main feedstocks include glucose and soybean meal, which together represent around 50-65% of total raw material expense. Other costs include mineral salts, nutrients, antifoaming agents, processing chemicals, and water.

Core process equipment, including bioreactors, sterilization systems, filtration units, ion-exchange columns, vacuum evaporators, and crystallizers, represents around 40-50% of the total streptomycin plant setup cost.

Purchased glucose and soybean meal together represent about 45-60% of variable operating expenses. Energy used for sterilization, aeration, agitation, concentration, and drying accounts for around 12-18% of OPEX, while yield, fermentation efficiency, purification losses, labor, and wastewater treatment also affect production costs.

Streptomycin manufacturing capacity is mainly concentrated in China, Japan, and India, supported by established fermentation and pharmaceutical manufacturing infrastructure.

The main grades include pharmaceutical-grade streptomycin sulfate and agricultural-grade streptomycin. Pharmaceutical grades are produced under controlled quality specifications for assay, purity, sterility, and related quality parameters, while agricultural grades are formulated for crop-protection applications.

Pharmaceutical manufacturing requires GMP compliance, validated processes, quality testing, documentation, and controlled manufacturing conditions. Depending on the target market and application, requirements may also include WHO prequalification, Japanese Pharmacopeia compliance, FDA or EMA requirements, DMF documentation, or agricultural product registration such as EPA registration.